Watch Demo

Growth Opportunities and Innovative Use Cases for AI in Clinical Trials

Growth Opportunities and Innovative Use Cases for AI in Clinical Trials

  • Publish Date:December 2022

  • Number of Pages:64

  • Report ID:6383513

  • Format:PDF

  • Publisher:Frost & Sullivan

$ 2450

Summary

As clinical pipelines globally witness a surge in novel complex therapies, the clinical trial industry demands new tools in predictive analytics to improve trial design, planning, and execution.

Artificial intelligence is gaining large-scale recognition as support for decentralized trial designs, thus enabling patient-centric clinical trial designs.

The rapid adoption of AI/ML algorithms and platforms to structure and utilize electronic health records (EHRs) allows the industry to tap into a vast, rich, and highly relevant data source that holds tremendous potential in improving the global clinical trial landscape. Incorporating integrated AI-driven solutions in clinical trial design and patient retention will ease the go-to-market strategy for various CROs and pharma players as they will reduce costs, increase efficiency, and support the transition to decentralized trials by means of remote patient recruitment, management, as well as engagement through interactive platforms thus ensuring higher retention.

Additionally, these platforms are highly beneficial in the selection of appropriate investigators and trial sites.

Randomized control trials (RCTs) are another possible application for sponsors to leverage AI in analyzing vast site-level datasets for greater insight into trial design and implementation.

Leading CROs such as Syneos Health or IQVIA, as well as several pharmaceutical companies such as BMS, have successfully deployed AI-based platforms to support site selection and patient recruitment.

Companies (including AstraZeneca and Novartis among others) are also applying AI in clinical trials to enable the optimization of different stages with the intent of reducing the overall trial timelines.

AI technologies bring fundamental innovations for transforming clinical trials, such as collecting and analyzing real-world data, seamlessly combining phases I and II of clinical trials, and developing novel patient-centered endpoints.

AI can be leveraged to create standardized, structured, and digital data elements from a range of inputs, and as AI-enabled study design helps optimize and accelerate the creation of patient-centric designs, it significantly reduces patient burden, increases the likelihood of success, decreases the number of amendments, and improves the overall efficiency of trials.

Together, big technology providers and pharmaceutical start-ups are setting the course for more effective clinical trials in the future.

Table of contents

Strategic Imperatives
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on Artificial Intelligence (AI) in the Clinical Trials Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Growth Opportunity Analysis
Scope of Analysis
Definitions
Segmentation
The Top 3 Clinical Trial Challenges
The AI Value Proposition in Clinical Trials
Why AI Is Critical for Trial Success
The Patient Journey Through AI-enabled Clinical Trials
Growth Drivers
Growth Restraints
Regulatory Scenario - AI Use in Clinical Trials
Vendor Ecosystem
AI in Clinical Trials - Companies-to-Action (C2A) Targets
AI in Clinical Trials - Adoption Timeline and Impact
Use Case - Clinical Trial Design
AI Applications in Clinical Trial Design
Vendor Spotlight - Owkin
Industry Use Case and Analyst Perspective
Vendor Spotlight - ConcertAI
Industry Use Case and Analyst Perspective
Other AI Vendors in Clinical Trial Design
Use Case - Patient Enrichment, Recruitment, and Enrollment
AI Application in Patient Enrichment, Recruitment, and Enrollment
Vendor Spotlight - Unlearn
Industry Use Case and Analyst Perspective
Vendor Spotlight - TrialWire
Analyst Perspective
Other AI Vendors for Patient Enrichment, Recruitment, and Enrollment
Use Case - Patient Monitoring, Medical Adherence, and Retention
AI Application in Patient Monitoring, Adherence, and Retention
Vendor Spotlight - AiCure
Industry Use Case and Analyst Perspective
Vendor Spotlight - AWS
Industry Use Case and Analyst Perspective
Other AI Vendors for Patient Monitoring, Adherence, and Retention
Use Case - Investigator and Site Selection
AI Applications in Investigator and Site Selection
Vendor Spotlight - Medidata AcornAI
Industry Use Case and Analyst Perspective
Vendor Spotlight - Deep 6 AI
Industry Use Case and Analyst Perspective
Other AI Vendors for Investigator and Site Selection
Other Companies to Watch
Other Companies to Watch

Growth Opportunity Universe
Growth Opportunity 1-Remote Recruitment to Expand Patient Diversity for Cancer Trials

Growth Opportunity 2-Patient-centric Clinical Trial Design for Better Retention and Monitoring

Growth Opportunity 3-AI-integrated Cloud-based SaaS Delivery Models

List of Exhibits
Legal Disclaimer

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.